Evidence map›Paper›PMID 26131619›Full record

ArticleACS chemical biology2015

Nucleotide Sugar Pucker Preference Mitigates Excision by HIV-1 RT.

Ken Yamada, Alexander S Wahba, Jean A Bernatchez, Tatiana Ilina, Saúl Martínez-Montero, Maryam Habibian, Glen F Deleavey, Matthias Götte, Michael A Parniak, Masad J Damha

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ken YamadaDepartment of Chemistry, McGill University , 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada.
Alexander S WahbaDepartment of Chemistry, McGill University , 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada.
Jean A BernatchezDepartment of Biochemistry, McGill University , 3655 Sir William Osler Promenade, Montreal, Quebec H3G1Y6, Canada.
Tatiana IlinaDepartment of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh , 450 Technology Drive, Pittsburgh, Pennsylvania 15219-3143, United States.
Saúl Martínez-MonteroDepartment of Chemistry, McGill University , 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada.
Maryam HabibianDepartment of Chemistry, McGill University , 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada.
Glen F DeleaveyDepartment of Chemistry, McGill University , 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada.
Matthias GötteDepartment of Biochemistry, McGill University , 3655 Sir William Osler Promenade, Montreal, Quebec H3G1Y6, Canada.
Michael A ParniakDepartment of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh , 450 Technology Drive, Pittsburgh, Pennsylvania 15219-3143, United States.
Masad J DamhaDepartment of Chemistry, McGill University , 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada.
McGill University · CAUniversity of Pittsburgh · US

Funding

Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIVR01AI076119 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI SARAFIANOS, STEFAN G · 2008 to 2018
$4.1M
Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIVR37AI076119 · NIAID · EMORY UNIVERSITY · PI Stefan G Sarafianos · 2020 to 2026
$3.6M
Microbicide properties of RT inhibitor combinationsR33AI079801 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PARNIAK, MICHAEL A · 2010 to 2012
$1.4M
Microbicide properties of RT inhibitor combinationsR21AI079801 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PARNIAK, MICHAEL A · 2008 to 2009
$421k
CIHRNIAID NIH HHS AI076119NIAID NIH HHS AI079801NIAID NIH HHS R01 AI076119NIAID NIH HHS R21 AI079801NIAID NIH HHS R33 AI079801NIAID NIH HHS R37 AI076119
6 · The paper itself

Abstract

A series of DNA primers containing nucleotides with various sugar pucker conformations at the 3'-terminus were chemically synthesized by solid-phase synthesis. The ability of wild-type (WT) HIV-1 reverse transcriptase (RT) and AZT-resistant (AZTr) RT to excise the 3'-terminal nucleotide was assessed. Nucleosides with a preference for the North conformation were more refractory to excision by both WT-RT and AZTr-RT. We found that DNA primers that contain North puckered-nucleotides at the 3'-terminus can also affect the translocation status of the RT/template/primer complex, which provides an underlying mechanism to avoid being excised. Together, these results point to a correlation between the sugar conformation of the 3'-terminal nucleotide, the precise position of HIV-1 RT on its nucleic acid substrate, and, in turn, its catalytic function. Nucleotide sugar conformation is therefore an important parameter in defining the susceptibility to RT-catalyzed phosphorolytic excision.

Indexed as

Anti-HIV AgentsDrug Resistance, ViralHIV-1HIV InfectionsHIV Reverse TranscriptaseHumansModels, MolecularNucleosidesSolid-Phase Synthesis TechniquesZidovudineAnti-HIV AgentsHIV Reverse TranscriptaseNucleosidesreverse transcriptase, Human immunodeficiency virus 1Zidovudine

Identifiers

PMID26131619
PMCPMC7012501
OpenAlexW2462336466

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.